Emerging 8-methoxyfluoroquinolone resistance among methicillin-susceptible Staphylococcus epidermidis isolates recovered from patients with endophthalmitis

Journal of Clinical Microbiology

Volumn 51, Issue 9, 2013, Pages 2959-2963

  Bispo, Paulo J M ^a,b   Alfonso, Eduardo C ^a   Flynn, Harry W ^a   Miller, Darlene ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GATIFLOXACIN; GLUTAMIC ACID; LEVOFLOXACIN; LYSINE; MOXIFLOXACIN; OFLOXACIN; PHENYLALANINE; SERINE; VANCOMYCIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; CODON; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; ENDOPHTHALMITIS; FEMALE; GYRA GENE; HUMAN; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS EPIDERMIDIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARC GENE; POINT MUTATION; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; ENDOPHTHALMITIS; FEMALE; FLUOROQUINOLONES; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION, MISSENSE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84882748789     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00846-13     Document Type: Article

References (29)

1. Benz MS, Scott IU, Flynn HW, Jr, Unonius N, Miller D. 2004. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of cultureproven cases. Am. J. Ophthalmol. 137:38-42.
2. Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF. 1996. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am. J. Ophthalmol. 122:1-17.
3. Melo GB, Bispo PJ, Yu MC, Pignatari AC, Hofling-Lima AL. 2011. Microbial profile and antibiotic susceptibility of culture-positive bacterial endophthalmitis. Eye (Lond.) 25:382-388.
4. Kim SJ, Toma HS, Midha NK, Cherney EF, Recchia FM, Doherty TJ. 2010. Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections. Ophthalmology 117:2372-2378.
5. Park SH, Lim JA, Choi JS, Kim KA, Joo CK. 2009. The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics. Cornea 28:68-72.
6. Chang DF, Braga-Mele R, Mamalis N, Masket S, Miller KM, Nichamin LD, Packard RB, Packer M. 2007. Prophylaxis of postoperative endophthalmitis after cataract surgery: results of the 2007 ASCRS member survey. J. Cataract Refract. Surg. 33:1801-1805.
7. Scoper SV. 2008. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in vitro and in vivo efficacy. Adv. Ther. 25:979-994.
8. McDonald M, Blondeau JM. 2010. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones. J. Cataract Refract. Surg. 36:1588-1598.
9. Miller D, Flynn PM, Scott IU, Alfonso EC, Flynn HW Jr. 2006. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch. Ophthalmol. 124:479-483.
10. Schimel AM, Miller D, Flynn HW. 2012. Evolving fluoroquinolone resistance among coagulase-negative Staphylococcus isolates causing endophthalmitis. Arch. Ophthalmol. 130:1617-1618.
11. Major JC, Jr, Engelbert M, Flynn HW, Jr, Miller D, Smiddy WE, Davis JL. 2010. Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am. J. Ophthalmol. 149:278-283.
12. Morrissey I, Burnett R, Viljoen L, Robbins M. 2004. Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002. J. Infect. 49:109-114.
13. Oliveira AD, D'Azevedo PA, Francisco W. 2007. In vitro activity of fluoroquinolones against ocular bacterial isolates in Sao Paulo, Brazil. Cornea 26:194-198.
14. Asbell PA, Colby KA, Deng S, McDonnell P, Meisler DM, Raizman MB, Sheppard JD, Jr, Sahm DF. 2008. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am. J. Ophthalmol. 145:951-958.
15. Haas W, Pillar CM, Torres M, Morris TW, Sahm DF. 2011. Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular MicRorganisms (ARMOR) 2009 Surveillance study. Am. J. Ophthalmol. 152:567-574.
16. Marangon FB, Miller D, Muallem MS, Romano AC, Alfonso EC. 2004. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am. J. Ophthalmol. 137:453-458.
17. Betanzos-Cabrera G, Juarez-Verdayes MA, Gonzalez-Gonzalez G, Cancino-Diaz ME, Cancino-Diaz JC. 2009. Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis. Ophthalmic Res. 42:43-48.
18. Miyanaga M, Nejima R, Miyai T, Miyata K, Ohashi Y, Inoue Y, Toyokawa M, Asari S. 2009. Changes in drug susceptibility and the quinolone-resistance determining region of Staphylococcus epidermidis after administration of fluoroquinolones. J. Cataract Refract. Surg. 35:1970-1978.
19. Yamada M, Yoshida J, Hatou S, Yoshida T, Minagawa Y. 2008. Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones. Br. J. Ophthalmol. 92:848-851.
20. Deramo VA, Lai JC, Fastenberg DM, Udell IJ. 2006. Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin. Am. J. Ophthalmol. 142:721-725.
21. Moshirfar M, Feiz V, Vitale AT, Wegelin JA, Basavanthappa S, Wolsey DH. 2007. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series. Ophthalmology 114:686-691.
22. Hori Y, Nakazawa T, Maeda N, Sakamoto M, Yokokura S, Kubota A, Inoue T, Nishida K, Tano Y. 2009. Susceptibility comparisons of normal preoperative conjunctival bacteria to fluoroquinolones. J. Cataract Refract. Surg. 35:475-479.
23. Kim SJ, Toma HS. 2011. Ophthalmic antibiotics and antimicrobial resistance: a randomized, controlled study of patients undergoing intravitreal injections. Ophthalmology 118:1358-1363.
24. Moss JM, Sanislo SR, Ta CN. 2010. Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections. Ophthalmology 117:2141-2145.
25. He L, Ta CN, Mino de Kaspar H. 2009. One-day application of topical moxifloxacin 0.5% to select for fluoroquinolone-resistant coagulasenegative Staphylococcus. J. Cataract Refract. Surg. 35:1715-1718.
26. Donnenfeld ED, Comstock TL, Proksch JW. 2011. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application. J. Cataract Refract. Surg. 37:1082-1089.
27. Olofsson SK, Cars O. 2007. Optimizing drug exposure to minimize selection of antibiotic resistance. Clin. Infect. Dis. 45(Suppl 2):S129-S136.
28. Iihara H, Suzuki T, Kawamura Y, Ohkusu K, Inoue Y, Zhang W, Monir Shah M, Katagiri Y, Ohashi Y, Ezaki T. 2006. Emerging multiple mutations and high-level fluoroquinolone resistance in methicillin-resistant Staphylococcus aureus isolated from ocular infections. Diagn. Microbiol. Infect. Dis. 56:297-303.
29. Noguchi N, Okihara T, Namiki Y, Kumaki Y, Yamanaka Y, Koyama M, Wakasugi K, Sasatsu M. 2005. Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002. Int. J. Antimicrob. Agents 25:374-379.